Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neuroscie...(a. It is also distributed and sold inthe...)

Date:12/21/2007

a. It is also distributed and sold in the EU as NeuroBloc. MYOBLOC is indicated for the treatment of patients with cervical dystonia (CD) to reduce the severity of abnormal head position and pain associated with CD. For more information about Solstice Neurosciences, Inc., visit http://www.solsticeneuro.com.

Myobloc(R) and NeuroBloc(R) are registered trademarks of Solstice Neurosciences, Inc.

'/>"/>

SOURCE Solstice Neurosciences, Inc. Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related biology technology :

1. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
2. Insmed Appoints Dennis M. Lanfear to Board Of Directors
3. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
4. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
5. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
6. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
7. KGI and Smith College Establish Leadership Forum for Women in Bioscience
8. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
9. Orchid Cellmark Appoints James F. Smith Chief Financial Officer
10. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
11. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System